U.S. Stock News

NYSE:SHW
NYSE:SHWChemicals

Sherwin Williams (SHW) Draws Valuation Focus, Is The Stock Still Undervalued?

Sherwin-Williams (SHW) is back in focus after recent share price moves, with the stock closing at $338.14. That puts fresh attention on how its current valuation lines up with fundamentals. See our latest analysis for Sherwin-Williams. The recent move to $338.14 comes after a 1-day share price return of 1.76% and a 30-day share price return of 4.87%. The 1-year total shareholder return of 0.41% and 5-year total shareholder return of 25.61% suggest longer term momentum has been relatively...
NasdaqGS:EXTR
NasdaqGS:EXTRCommunications

Extreme Networks (EXTR) Stock May Be 16% Undervalued Following Data Center Demand News

Extreme Networks stock has delivered a very strong 194.9% return over the past five years, and today the valuation picture shows a company that still screens as undervalued on both intrinsic value estimates and market multiples, but with only a mixed score when all checks are considered together. Over five years, Extreme Networks is up 194.9%, which puts recent pullbacks in a longer trend of substantial value creation for shareholders. Growing demand for data center networking equipment...
NasdaqGM:APPF
NasdaqGM:APPFSoftware

AppFolio (APPF) Rebound Following Cloud Growth Narrative Leaves Valuation Question Open

AppFolio (APPF) has drawn fresh attention after recent share price moves, with the stock up about 15% over the past month and roughly 16% over the past 3 months. See our latest analysis for AppFolio. Zooming out, AppFolio’s recent 1 month share price return of about 15% follows a period where the year to date share price return is down roughly 21% and the 1 year total shareholder return has declined about 29%. The latest bounce suggests improving short term momentum after a weaker stretch for...
NYSE:ACHR
NYSE:ACHRAerospace & Defense

Archer Aviation (ACHR) Following ACES And Zee Launches Has Its Valuation Back In Focus

Archer Aviation (ACHR) is in focus after two fresh announcements: a nationwide eVTOL charging consortium with BETA Technologies and Macquarie Capital, and Zee, an AI aviation platform aimed at flight safety and operational efficiency. See our latest analysis for Archer Aviation. Despite the ACES consortium and Zee announcements, Archer Aviation’s recent trading has been weak, with the share price at $4.49 and the 1-year total shareholder return down 66.49%. This suggests momentum has been...
NasdaqGS:IBKR
NasdaqGS:IBKRCapital Markets

Interactive Brokers Group (IBKR) On Earnings Upgrades And Crypto Expansion Looks Close To Fair Value

Interactive Brokers Group (IBKR) is back in focus after analysts raised earnings estimates and the company rolled out a fresh expansion of its cryptocurrency platform, including new tradable tokens and broader stablecoin funding tools. See our latest analysis for Interactive Brokers Group. Even after the earnings upgrades and the crypto platform expansion, Interactive Brokers Group’s share price has pulled back, with the stock down 5.34% over the last day and 3.22% over the past week. It...
NYSE:PLGO
NYSE:PLGOInsurance

Pelagos Insurance Capital (PLGO) Rides Pricing And Tech Optimism On A Fair Value Debate

Recent commentary around Pelagos Insurance Capital (PLGO) centers on expectations that better pricing, product redesigns, and new technology, combined with disciplined underwriting and diversification, are supporting a more constructive view of the stock’s risk and return profile. See our latest analysis for Pelagos Insurance Capital. At a share price of $25.44, Pelagos Insurance Capital has seen momentum build recently, with a 30 day share price return of 7.71% and a 1 year total shareholder...
NYSE:AMRC
NYSE:AMRCConstruction

Ameresco (AMRC) Lands Philadelphia Solar Project On A Bullish Valuation Narrative

Ameresco (AMRC) is back in focus after announcing a rooftop solar project for the Community College of Philadelphia, adding two new solar arrays under Pennsylvania’s Solar for Schools program and an energy performance contract. See our latest analysis for Ameresco. For context, Ameresco’s share price has retreated in the short term, with the stock down 4.42% over the past day and 13.11% over the past month. Its 1 year total shareholder return of 28.49% contrasts with much weaker 3 and 5 year...
NYSE:BW
NYSE:BWElectrical

Babcock & Wilcox Enterprises (BW) Launches Buyback And Debt Redemption, Is It Still Undervalued?

Babcock & Wilcox Enterprises (BW) has moved to redeem all $61.4 million of its 6.50% Senior Notes due 2026, while also launching a new share repurchase program of up to $50 million. See our latest analysis for Babcock & Wilcox Enterprises. Babcock & Wilcox Enterprises’ new buyback and debt redemption plans arrive after a sharp pullback in recent weeks, with the share price down 39.69% over 30 days and 45.37% over 90 days, yet still showing a 57.95% year to date share price return and a very...
NYSE:VSXY
NYSE:VSXYSpecialty Retail

Is Victoria's Secret (VSXY) Comfort-First PINK Marshmallow Line the Key to Its Brand Reset?

In early July 2026, Victoria’s Secret PINK launched Marshmallow, a new comfort-focused bra collection featuring four wireless silhouettes in inclusive sizes from XXS–XXL and SDD–LDD, priced between US$29.95 and US$49.95. By emphasizing buttery soft, four-way stretch fabrics, pull-on designs, and lifestyle-specific wear, Marshmallow deepens PINK’s comfort and versatility positioning within Victoria’s Secret’s broader bra portfolio. Next, we’ll explore how this comfort-centric, inclusive...
NYSE:WT
NYSE:WTCapital Markets

WisdomTree (WT) Looks Fully Valued As Space ETF Launch Draws Fresh Attention

WisdomTree (WT) is attracting fresh attention after launching the WisdomTree Space Economy Fund (WSPC) on Nasdaq, an actively managed ETF targeting companies tied to launch infrastructure, commercial space, defense applications, and emerging orbital technologies. See our latest analysis for WisdomTree. That launch lands at a time when WisdomTree’s momentum is already strong, with the share price at $20.16 and a 61.15% year to date share price return, alongside a very large 5 year total...
NYSE:INSW
NYSE:INSWOil and Gas

International Seaways (INSW) Stock Looks Fully Priced Following Its 7.6x Five Year Run

International Seaways has delivered a very large 5 year return, while the current valuation checks suggest the stock now sits closer to fairly priced than clearly cheap. This leaves investors weighing strong past gains against a more measured valuation signal. Over 5 years, International Seaways has returned roughly 7.6x, which puts extra focus on whether recent share price strength can be supported over time. Future cash generation from the shipping fleet can support the current share...
NYSE:EFX
NYSE:EFXProfessional Services

Equifax (EFX) Stock Could Be A Bargain On Cash Flow Yet Full On Earnings

Equifax stock has fallen 30.6% over the past year, yet the current valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while earnings-based multiples suggest the shares trade on the expensive side. Over the past 1 year, Equifax has declined 30.6%, which puts the recent share price under pressure even before considering what any valuation model implies. Planned expansion in Mexico through the agreed US$750m acquisition of...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

Viatris (VTRS) Draws Fresh Attention Following Pain Management Partnership And Undervalued Narrative

Why Viatris Stock Is Back on Investors’ Radar Viatris (VTRS) is drawing attention after its role as a founding partner in the American Academy of Orthopaedic Surgeons’ new Pain Management Resource Center, a project focused on musculoskeletal pain care. This partnership arrives as Viatris trades at US$17.33, following a 3.8% move on July 16, 2026. This is prompting questions about how its healthcare collaborations and current valuation fit into a broader investment thesis. See our latest...
NYSE:BSX
NYSE:BSXMedical Equipment

Boston Scientific (BSX) Recalls Endoscopy Devices, Is The Stock A Bargain?

Boston Scientific (BSX) is under scrutiny after a series of voluntary Class II recalls of its CRE and CRE Pro Wireguided endoscopy devices, prompted by potential sterile packaging breaches affecting tens of thousands of units globally. See our latest analysis for Boston Scientific. The recalls arrive after a period of sharp share price weakness, with Boston Scientific’s stock down 30.53% on a 3 month share price return basis and 52.89% year to date. The 1 year total shareholder return has...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

What Teva Pharmaceutical Industries (TEVA)'s TEV‑408 Vitiligo Data and Funding Deal Means For Shareholders

Teva Pharmaceutical Industries recently reported encouraging Phase 1b data for its investigational anti‑IL‑15 antibody TEV‑408 in non‑segmental vitiligo, showing improved skin repigmentation with no new safety issues and confirming plans to move into a Phase 2b trial supported by up to US$500.00 million in external R&D funding. The quarterly subcutaneous dosing schedule and dual development in vitiligo and celiac disease position TEV‑408 as a potentially differentiated asset within Teva’s...
NasdaqGS:JBLU
NasdaqGS:JBLUAirlines

How JetBlue’s New ClarityPay Installment Program Could Shape JetBlue Airways (JBLU) Investors’ Outlook

Earlier this week, JetBlue and financial technology firm ClarityPay launched an embedded pay-later program that lets eligible customers finance bookings over 6-week to 48-month terms, including an introductory 0% APR for up to 12 months through mid-August 2026, while still earning TrueBlue points on eligible purchases. By integrating AI-driven, white-label financing directly into its booking and loyalty ecosystem, JetBlue is turning payment flexibility into a customer planning and conversion...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Synopsys (SNPS) Stock Could Trade Below Fair Value Despite Rich Earnings

Synopsys stock has pulled back over the past year, yet there is a clear split on value, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market multiples suggest the shares are on the expensive side. Over 5 years, Synopsys has delivered a gain of 48.1%, which puts the recent weakness into a longer track record of positive returns. The shift away from legacy manufacturing analytics toward AI driven chip design tools may support future cash flow,...
NYSE:ABBV
NYSE:ABBVBiotechs

AbbVie (ABBV) Boey Approval Puts Its Growth Story And Valuation Back In Focus

Why Boey’s European approval matters for AbbVie investors AbbVie (ABBV) is back in focus after Allergan Aesthetics secured European Commission approval for Boey, a rapid onset, short duration facial injectable that extends the company’s aesthetics reach across 30 European countries. This new product sits alongside growing interest in AbbVie’s neuroscience and immunology portfolios. It gives investors fresh information to consider when thinking about how different segments might support the...
NasdaqGS:HBT
NasdaqGS:HBTBanks

HBT Financial (HBT) Stock Looks Reasonable Rather Than Deeply Mispriced

After a 134.0% total return over the past 5 years, HBT Financial now trades at US$33.39. The central question is whether that performance is fully reflected in the price when set against its intrinsic value estimate and broader valuation checks. A 134.0% 5 year return indicates that long term shareholders in HBT Financial have already seen substantial value created, so any new position needs a clear view on remaining upside. The Excess Returns model suggests the intrinsic value sits...
NYSE:ARCO
NYSE:ARCOHospitality

How Investors Are Reacting To Arcos Dorados (ARCO) Redeeming Its 6.125% Sustainability-Linked Notes

Arcos Dorados Holdings Inc. has moved to redeem all of its outstanding 6.125% sustainability-linked senior notes due 2029, at 103.063% of principal plus accrued interest, with the redemption completed on July 16, 2026. This decision reshapes the company’s capital structure by retiring a relatively high-coupon instrument, potentially improving interest expense efficiency and highlighting management’s focus on balance sheet quality and financial flexibility. Next, we’ll examine how retiring...
NYSE:V
NYSE:VDiversified Financial

Visa Stock And 2 Fintech Picks For Rising Payment Fraud

Organized retail crime and rising tap to pay fraud are putting a fresh spotlight on the payment technology and fintech space, as retailers face security gaps, rising chargebacks, and the potential impact of new legislation like the Combating Organized Retail Crime Act. For investors, the question is which stocks could see stronger demand for their tools and services as the cost of fraud climbs toward an estimated $1b a year, and which might face higher risk. This article looks at 3 stocks...
NYSE:RNG
NYSE:RNGSoftware

RingCentral (RNG) Could Be 8% Undervalued After Mixed Earnings Signals

RingCentral (RNG) is back in focus after a mixed quarterly update, with revenue of $644.2 million meeting expectations while full-year EPS guidance topped forecasts, but billings and peer-relative performance fell short. See our latest analysis for RingCentral. RingCentral’s latest results landed after a strong run, with a 1-month share price return of 9.78% and year to date share price return of 51.40%. However, the stock is still working through mixed sentiment following the post earnings...
NYSE:FOUR
NYSE:FOURDiversified Financial

How Investors May Respond To Shift4 Payments (FOUR) Integrating Tax‑Free Shopping Into Its New European Device

Earlier this week, Shift4 Payments launched Shift4 One, an all‑in‑one handheld solution that combines payments, dynamic currency conversion, and tax‑free shopping, initially rolled out across the UK, Ireland, Spain and Germany with plans to reach 15 European countries by year‑end. The product is the first jointly developed offering since Shift4 acquired Global Blue, pairing Shift4’s payment capabilities with Global Blue’s tax‑refund expertise to automate eligibility detection and streamline...
NYSE:IONQ
NYSE:IONQTech

IonQ (IONQ) After Raised Guidance And Backlog Growth Faces A Valuation Test

IonQ (IONQ) has grabbed attention after reporting strong revenue growth, a sharp jump in its customer backlog to about US$470 million, and lifting full year guidance to a range of US$260 million to US$270 million. See our latest analysis for IonQ. Despite the upbeat revenue and backlog news, IonQ's recent share price return has been weak, with the stock down 6.42% over one day, 37.39% over 30 days, and 24.95% year to date, while the 5 year total shareholder return of 252.41% still reflects...